Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Atul C. Mehta, M.B., B.S., specialty interests are the treatment of lung cancer, diagnostic and therapeutic bronchoscopy, lung transplantation, interstitial lung diseases and pulmonary hypertension. He is board-certified in internal medicine, pulmonary disease and critical care medicine. Dr. Mehta's research interests are therapeutic bronchoscopy, lung transplantation and idiopathic pulmonary fibrosis.
He was named in the 2000-2001 Top Doctors in America; 1999-2000 edition of Best Doctors in America; Who's Who in Medicine and Healthcare, 1997; Best Doctors in America- Midwest Region, 1996-1997; and International Who's Who, 1996-1997.
In 1993 he was awarded the Distinguished Physicians of the Year by the Indian Physicians of Northern Ohio and in 1992, the Cleveland Clinic's Bruce Hubbard Steward Award for his ability to combine sensitivity and compassion with knowledge and skill in the practice of medicine.
Dr. Mehta was the founder and president of the American Association for Bronchology. He is a Fellow of the American College of Chest Physicians, the American College of Physicians, and the American Society for Laser Medicine & Surgery. He also is an active member of the American Thoracic Society, International Bronchoesophagological Society, International Society for Heart & Lung Transplantation and World Association for Bronchology.
He serves on the editorial boards for several professional journals including the Journal of Bronchology, Lasers in Surgery and Medicine and Cleveland Clinic Journal of Medicine. He is a reviewer for CHEST, Cancer, American Journal of Respiratory and Critical Care Medicine, and the New England Journal of Medicine.
Dr. Mehta received his medical degree from Municipal Medical College, Gujarat University in India. Following his internship and residency training in India, he completed a general practice residency at Delaware County Memorial Hospital in Drexel Hill, Pa., and an internal medicine residency at Hahnamann Medical College Affiliate Hospitals in Trenton, N.J., and Easton, Pa. He completed a fellowship in pulmonary disease at Cleveland Clinic.
Advanced lung disease, asthma, congenital lung disease, lung cancer, lung transplantation, diagnosis and therapeutic bronchoscopy. Advanced lung disease, asthma, bronchitis, bronchogenic carcinoma, carcinoid syndrome, congenital lung disease, histoplasmosis, lambert-eaton myasthenic syndrome, lung cancer, malignant mesothelioma
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/21/2013, Dr. Mehta has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Consulting and/or Speaking. Dr. Mehta receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.